Niskakangas Anne, Mustonen Olli, Puro Iiris, Karjula Topias, Helminen Olli, Yannopoulos Fredrik
Research Unit of Translational Medicine, Medical Research Center Oulu, University of Oulu, Oulu, Finland.
Department of Gastrointestinal Surgery, Oulu University Hospital, Oulu, Finland.
Interdiscip Cardiovasc Thorac Surg. 2023 Dec 5;37(6). doi: 10.1093/icvts/ivad189.
The aim of this study was to compare the short- and long-term results of video-assisted thoracoscopic surgery (VATS) and thoracotomy for non-small-cell lung cancer in a medium-volume centre, where cardiothoracic surgeons perform both cardiac and general thoracic surgery. The primary outcome of interest was 5-year overall survival and disease-specific survival. Secondary outcomes were short-term postoperative complications, length of hospital stay and lymph node yield.
This was a retrospective cohort study including 670 lung cancer patients undergoing VATS (n = 207) or open surgery (n = 463) with a curative intent in Oulu University Hospital between the years 2000-2020. Propensity score matching was implemented with surgical technique as the dependent and age, sex, Charlson comorbidity index, pulmonary function, pathological stage, histological type and the year of the operation as covariates resulting in 127 pairs.
In the propensity-matched cohort, 5-year overall survival was 64.3% after VATS and 63.2% after thoracotomy (P = 0.969). Five-year disease-specific survival was 71.6% vs 76.2% (P = 0.559). There were no differences in overall (34.6% vs 44.9%, p = 0.096) or major postoperative complications (8.7% vs 14.2%, P = 0.167) between the study groups. The average length of hospital stay was shorter (5.8 vs 6.6 days, P = 0.012) and the median lymph node yield was lower (4.0 vs 7.0, P < 0.001) in the VATS group compared to the thoracotomy group.
According to this study, the long-term results of lung cancer surgery in a mixed practice are comparable between VATS and open surgery.
本研究旨在比较在一个开展心脏和普通胸外科手术的中等规模中心,电视辅助胸腔镜手术(VATS)与开胸手术治疗非小细胞肺癌的短期和长期结果。主要关注的结局是5年总生存率和疾病特异性生存率。次要结局包括术后短期并发症、住院时间和淋巴结获取数量。
这是一项回顾性队列研究,纳入了2000年至2020年期间在奥卢大学医院接受VATS(n = 207)或根治性开胸手术(n = 463)的670例肺癌患者。以手术技术为因变量,年龄、性别、Charlson合并症指数、肺功能、病理分期、组织学类型和手术年份作为协变量进行倾向评分匹配,最终得到127对匹配病例。
在倾向评分匹配队列中,VATS术后5年总生存率为64.3%,开胸手术后为63.2%(P = 0.969)。5年疾病特异性生存率分别为71.6%和76.2%(P = 0.559)。两组之间的总体并发症(34.6%对44.9%,p = 0.096)或主要术后并发症(8.7%对14.2%,P = 0.167)无差异。与开胸手术组相比,VATS组的平均住院时间更短(5.8天对6.6天,P = 0.012),中位淋巴结获取数量更低(4.0对7.0,P < 0.001)。
根据本研究,在综合医疗实践中,VATS和开胸手术治疗肺癌的长期结果具有可比性。